L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will include women who will undergo pelvic reconstructive surgery and/or
anti-incontinence sling procedures. Patients will be randomized to the combination of
L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract in tablet or placebo twice a day
during the seven days before and after surgery (total of 14 days). In this randomized,
double-blind study, the investigators will assess treatment of clinically suspected or
culture-proven urinary tract infections within 3 weeks of surgery (primary outcome), and risk
factors for treatment for postoperative urinary tract infections (secondary outcomes) between
the two study groups.